Patents by Inventor Katherine Anne Morgan

Katherine Anne Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250009917
    Abstract: The present invention relates to compounds of formula (I) that have the ability to be used as metal complexes in radiotherapy. wherein A is selected from the group consisting of CO2R1, and PO3R1; B is selected from the group consisting of CO2R2, and PO3R2; R1, R2 and R3 are each independently selected from the group consisting of H and C1-C12alkyl; each Ra is independently selected from the group consisting of H, F, Cl, Br, I, CH3, CH2CH3, CH(CH3)2, OH, OCH3, OCH2CH3, CF3, OCF3, NO2, NH2, and CN; each Rb is independently selected from the group consisting of H, F, Cl, Br, I, CH3, CH2CH3, CH(CH3)2, OH, OCH3, OCH2CH3, CF3, OCF3, NO2, NH2, and CN; L is a linker having from 1 to 20 atoms in the normal chain; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 29, 2022
    Publication date: January 9, 2025
    Inventors: Katherine Anne Morgan, Paul Stephen Donnelly, Christian Werner Wichmann, Andrew Mark Scott
  • Publication number: 20230065420
    Abstract: The present invention relates to methods of diagnosis and therapy for neurodegenerative diseases and disorders.
    Type: Application
    Filed: December 11, 2020
    Publication date: March 2, 2023
    Applicant: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Katherine Anne Morgan